Jefferies is out with its report today on Health Management Association HMA, lowering its PT from $13 to $12.
In its report, Jefferies writes, "Good Q2 results should rekindle investors' enthusiasm not only for HMA but
also for the entire hospital sector as acuity weakness seen at HCA HCA may not be systemic. We would be buyers of HMA at this discounted price. PT: $12 (from $13)."
Jefferies maintains Buy on HMA.
Shares of HMA closed Wednesday at $9.30.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in